Therapeutic Plasma Exchange is Effective in severe COVID-19 Patients?
What is Therapeutic Plasma Exchange?
Therapeutic Plasma Exchange (TPE) is a procedure in which the patient's blood is passed through an apheresis machine, where the filtered plasma is removed and discarded with reinfusion of red blood cells along with replacement fluid such as plasma. Plasma exchange, also known as plasmapheresis, is a way to "clean" your blood. It works sort of like kidney dialysis. During the treatment, plasma the liquid part of blood gets replaced with plasma from a donor or with a plasma substitute.
Where we use Therapeutic Plasma Exchange Techniques?
he "Therapeutic Plasma Exchange Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of in therapeutic plasma exchange market with detailed market segmentation by type, application and geography. The therapeutic plasma exchange market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in therapeutic plasma exchange market players and offers key trends and opportunities in the market.
Top Key Players of Therapeutic Plasma Exchange:
- Asahi Kasei Corporation
- Braun Melsungen AG
- Baxter International, Inc.
- Cerus Corporation
- Fresenius Kabi AG
- Haemonetics Corporation
- Hemacare Corporation
- Kawasumi Laboratories, Inc.
- Medica S.p.A
- Terumo Corporation
Comments
Post a Comment